ACRX : Summary for AcelRx Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

AcelRx Pharmaceuticals, Inc. (ACRX)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.100.00 (0.00%)
At close: 4:00PM EST
People also watch
ALIMAVEOAEGRECYTFOLD
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.10
Open3.15
Bid2.05 x 100
Ask3.50 x 2600
Day's Range3.00 - 3.15
52 Week Range2.40 - 4.50
Volume149,504
Avg. Volume222,619
Market Cap140.53M
Beta2.69
PE Ratio (TTM)-3.18
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer

    REDWOOD CITY, Calif., Feb. 16, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, announced that Vincent J. Angotti has been appointed chief executive officer and a member of the company's board of directors, effective Monday, March 6, 2017. Mr. Angotti brings over two decades of experience leading executive and commercial teams at public and private life sciences companies, most recently as CEO of XenoPort, Inc., a biopharmaceutical company focused on the development of treatments for neuropathic pain and other neurological disorders. Mr. Angotti succeeds Howie Rosen, who will continue on the AcelRx board of directors, where he has served since 2008.

  • PR Newswire6 days ago

    AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA™ for Use in Burn Victims with Moderate-to-Severe Acute Pain

    REDWOOD CITY, Calif., Feb. 13, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies ...

  • PR Newswire12 days ago

    AcelRx Pharmaceuticals to Participate at Four Upcoming Investor Events in February

    REDWOOD CITY, Calif., Feb. 7, 2017 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative ...